The Weed Science Society of America (WSSA) and its member scientists are continually exploring ways to facilitate increased ...

ConductorOne, the first AI-native identity platform that protects every identity — human, non-human, and AI — today announced its AI Access Management product extension, a unified control plane for ...

CallRevu, the industry leader in automotive communication intelligence, today announces the launch of its Partner Code of Ethics—a formal framework that codifies the standards every CallRevu partner ...

The V.I. Public Finance Authority on Wednesday approved two major contract extensions for the Office of Disaster Recovery, authorizing up to $25,632,361 per year for Ernst & Young and up to ...

As of the end of September, Ecopetrol Group's cash position stood at COP 14.1 trillion, reflecting an increase of COP 1 ...

New analyses show DLB patients with lower plasma pTau181 levels - indicating an earlier stage of disease and absence of ...

The announcement video has received a thumbs-up from just 16 percent of viewers.

Results supported by key neuroaxonal injury biomarkers pNfH and NfL after six months of treatmentAP-101 is an investigational human-derived antibody therapeutic that selectively targets the misfolded, ...

A few dark specks on a sheet, windowsill, or skirting board can make an ordinary room feel suddenly suspect. The reaction is usually immediate and deeply familiar. Disgust arrives first, closely ...

We've graded more than 60 signings and trades over the past few weeks. But only 16 moves received top marks. We ranked those deals.

Stoke Therapeutics is developing a drug designed to reduce seizures and restore some of their lost developmental function.

If you have not had a chance to review our quarterly earnings release, it can be found on our website at seraprognostics.com.